Nuveen California Select Tax-Free Income Portfolio (NXC) Competitors $12.72 +0.17 (+1.31%) Closing price 03:57 PM EasternExtended Trading$12.72 0.00 (0.00%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXC vs. HQL, MIN, MHN, JOF, ASG, AEF, MMT, BKT, TPVG, and IIFShould you be buying Nuveen California Select Tax-Free Income Portfolio stock or one of its competitors? The main competitors of Nuveen California Select Tax-Free Income Portfolio include Abrdn Life Sciences Investors (HQL), MFS Intermediate Income Trust (MIN), BlackRock MuniHoldings New York Quality Fund (MHN), Japan Smaller Capitalization Fund (JOF), Liberty All-Star Growth Fund (ASG), Abrdn Emerging Markets Equity Income Fund (AEF), MFS Multimarket Income Trust (MMT), BlackRock Income Trust (BKT), TriplePoint Venture Growth BDC (TPVG), and Morgan Stanley India Investment Fund (IIF). These companies are all part of the "financial services" industry. Nuveen California Select Tax-Free Income Portfolio vs. Abrdn Life Sciences Investors MFS Intermediate Income Trust BlackRock MuniHoldings New York Quality Fund Japan Smaller Capitalization Fund Liberty All-Star Growth Fund Abrdn Emerging Markets Equity Income Fund MFS Multimarket Income Trust BlackRock Income Trust TriplePoint Venture Growth BDC Morgan Stanley India Investment Fund Nuveen California Select Tax-Free Income Portfolio (NYSE:NXC) and Abrdn Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, community ranking, valuation, profitability, risk, earnings, institutional ownership and media sentiment. Does the MarketBeat Community favor NXC or HQL? Abrdn Life Sciences Investors received 95 more outperform votes than Nuveen California Select Tax-Free Income Portfolio when rated by MarketBeat users. CompanyUnderperformOutperformNuveen California Select Tax-Free Income PortfolioN/AN/AAbrdn Life Sciences InvestorsOutperform Votes9568.35% Underperform Votes4431.65% Which has more risk & volatility, NXC or HQL? Nuveen California Select Tax-Free Income Portfolio has a beta of 0.23, indicating that its share price is 77% less volatile than the S&P 500. Comparatively, Abrdn Life Sciences Investors has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500. Do institutionals & insiders believe in NXC or HQL? 11.9% of Nuveen California Select Tax-Free Income Portfolio shares are held by institutional investors. Comparatively, 32.2% of Abrdn Life Sciences Investors shares are held by institutional investors. 1.0% of Nuveen California Select Tax-Free Income Portfolio shares are held by insiders. Comparatively, 10.1% of Abrdn Life Sciences Investors shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is NXC or HQL a better dividend stock? Nuveen California Select Tax-Free Income Portfolio pays an annual dividend of $0.55 per share and has a dividend yield of 4.3%. Abrdn Life Sciences Investors pays an annual dividend of $1.47 per share and has a dividend yield of 11.8%. Does the media prefer NXC or HQL? In the previous week, Abrdn Life Sciences Investors had 3 more articles in the media than Nuveen California Select Tax-Free Income Portfolio. MarketBeat recorded 5 mentions for Abrdn Life Sciences Investors and 2 mentions for Nuveen California Select Tax-Free Income Portfolio. Nuveen California Select Tax-Free Income Portfolio's average media sentiment score of 1.52 beat Abrdn Life Sciences Investors' score of 0.70 indicating that Nuveen California Select Tax-Free Income Portfolio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nuveen California Select Tax-Free Income Portfolio 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Abrdn Life Sciences Investors 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation & earnings, NXC or HQL? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNuveen California Select Tax-Free Income Portfolio$5.49M14.73N/AN/AN/AAbrdn Life Sciences Investors$86.69M4.16N/AN/AN/A Is NXC or HQL more profitable? Company Net Margins Return on Equity Return on Assets Nuveen California Select Tax-Free Income PortfolioN/A N/A N/A Abrdn Life Sciences Investors N/A N/A N/A SummaryAbrdn Life Sciences Investors beats Nuveen California Select Tax-Free Income Portfolio on 7 of the 9 factors compared between the two stocks. Get Nuveen California Select Tax-Free Income Portfolio News Delivered to You Automatically Sign up to receive the latest news and ratings for NXC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXC vs. The Competition Export to ExcelMetricNuveen California Select Tax-Free Income PortfolioInvestment offices IndustryFinance SectorNYSE ExchangeMarket Cap$80.96M$7.26B$11.13B$18.91BDividend Yield3.65%7.08%5.90%4.14%P/E RatioN/A3.4922.0632.57Price / Sales14.7323.5425.9828.52Price / CashN/A7.5117.5917.53Price / BookN/A0.892.644.45Net IncomeN/A$66.51M$1.03B$1.02B7 Day Performance1.56%2.12%2.63%3.51%1 Month Performance-3.78%-3.64%-1.91%-5.38%1 Year Performance-1.09%1.90%537.01%4.23% Nuveen California Select Tax-Free Income Portfolio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXCNuveen California Select Tax-Free Income PortfolioN/A$12.73+1.3%N/A-2.7%$80.96M$5.49M0.00N/APositive NewsHigh Trading VolumeHQLAbrdn Life Sciences InvestorsN/A$11.78+2.6%N/A-4.1%$322.20M$86.69M0.00N/AMINMFS Intermediate Income TrustN/A$2.68+1.1%N/A+3.3%$304.98M$27.88M0.00N/ANews CoveragePositive NewsMHNBlackRock MuniHoldings New York Quality FundN/A$9.80+0.1%N/A-3.7%$296.37M$13.59M0.00N/APositive NewsJOFJapan Smaller Capitalization FundN/A$8.18+0.9%N/A+15.8%$288.13M$38.39M0.00N/AASGLiberty All-Star Growth FundN/A$4.78-0.6%N/A-7.0%$278.37M$51.46M0.00N/APositive NewsAEFAbrdn Emerging Markets Equity Income FundN/A$4.86+0.6%N/A+2.3%$246.66M$20.73M0.00N/APositive NewsMMTMFS Multimarket Income TrustN/A$4.45+0.9%N/A+0.9%$246.09M$45.79M0.00N/APositive NewsBKTBlackRock Income TrustN/A$11.45+1.5%N/A+3.2%$243.98M$3.59M0.00N/APositive NewsTPVGTriplePoint Venture Growth BDC1.8747 of 5 stars$5.99+2.0%$7.15+19.4%-35.2%$240.42M$45.53M28.53N/AUpcoming EarningsNews CoverageIIFMorgan Stanley India Investment FundN/A$23.92+0.9%N/A+12.4%$234.20M$63.07M0.00N/A Related Companies and Tools Related Companies HQL Alternatives MIN Alternatives MHN Alternatives JOF Alternatives ASG Alternatives AEF Alternatives MMT Alternatives BKT Alternatives TPVG Alternatives IIF Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NXC) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuveen California Select Tax-Free Income Portfolio Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuveen California Select Tax-Free Income Portfolio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NXC Stock Free NXC Stock Alerts